Stoke Therapeutics (STOK) EPS (2019 - 2026)
Stoke Therapeutics (STOK) EPS from Jun 30, 2019 to Mar 31, 2026. The TTM Stoke Therapeutics (STOK) EPS is -$2.91. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Stoke Therapeutics (STOK) EPS CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +5.94% |
| 5 Years TTM | +11.95% |
| All Time TTM | +15.10% |
Annual EPS change of Stoke Therapeutics (STOK)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.80 | +588.00% |
| 2025 | -$0.12 | -92.91% |
| 2024 | -$1.65 | -27.78% |
| 2023 | -$2.28 | -11.02% |
| 2022 | -$2.56 | +10.22% |
| 2021 | -$2.33 | +62.79% |
| 2020 | -$1.43 | +45.17% |
| 2019 | -$0.98 | N/A |
Comparison Stoke Therapeutics (STOK) five years EPS CAGR with competitors
Stoke Therapeutics (STOK) five years EPS CAGR is 11.95%.